Insights for Antihypertensive pharmacotherapy from the“Calcium Paradox” due to Ca2+/camp Interaction
Open Access
- 1 January 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 1 (1), 006-009
- https://doi.org/10.29328/journal.ach.1001002
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Challenges for the pharmacological treatment of neurological and psychiatric disorders: Implications of the Ca 2+ /cAMP intracellular signalling interactionEuropean Journal of Pharmacology, 2016
- Pharmacological implications of the Ca2+/cAMP signaling interaction: from risk for antihypertensive therapy to potential beneficial for neurological and psychiatric disordersPharmacology Research & Perspectives, 2015
- A Calcium Paradox in the Context of NeurotransmissionJournal of Pharmacy and Pharmacology, 2015
- Novel model for “calcium paradox” in sympathetic transmission of smooth muscles: Role of cyclic AMP pathwayCell Calcium, 2013
- Calcium Channel BlockersThe Journal of Clinical Hypertension, 2011
- Effects of low-dose nifedipine GITS on sympathetic activity in young and older patients with hypertensionJournal of Hypertension, 2004
- Interactions of calcium antagonists and the calcium channel agonist Bay K 8644 on neurotransmission of the mouse isolated vas deferensBritish Journal of Pharmacology, 1989
- Verapamil enhances the non-adrenergic twitch response of rat vas deferensEuropean Journal of Pharmacology, 1987
- A COMPARISON OF THE EFFECTS OF NIFEDIPINE AND VERAPAMIL ON RAT VAS DEFERENSBritish Journal of Pharmacology, 1981